女性患者术前白细胞增多预测完整肾下腹主动脉瘤EVAR术后不良结局
基于NSQIP数据库10,955例非破裂腹主动脉瘤EVAR患者,比较术前WBC<10 K/μL与≥10 K/μL的结局。WBC≥10 K/μL者30天死亡率2.4% vs 1.3%,且女性WBC≥10 K/μL者不良事件更多。结论认为WBC可预测EVAR术后不良结局,女性效应更显著。
要点
- 术前WBC≥10 K/μL与非破裂AAA EVAR术后30天死亡率、再入院等不良结局增加相关。
- 女性WBC≥10 K/μL者较男性WBC≥10 K/μL者死亡、住院>1周、再入院和下肢缺血更多。
- WBC每增加1 K/μL,校正后死亡、再入院、住院>1周及缺血性结肠炎风险均升高。
核心结论
- WBC是非破裂AAA患者EVAR术后不良结局的预测因素。
- 校正相关危险因素后,WBC升高的效应在女性患者中更显著。
- 术前WBC可作为EVAR术后不良结局的预后因素。
研究设计与样本
- 回顾性队列研究,使用血管靶向NSQIP数据库。
- 纳入10,955例接受EVAR的非破裂腹主动脉瘤患者,平均WBC 7.7 ± 2.7 K/μL。
- 按WBC<10 K/μL与WBC≥10 K/μL分组比较基线特征,采用多变量logistic回归评估结局。
- 主要结局为30天死亡率,次要结局包括住院>1周、30天再入院、下肢缺血、缺血性结肠炎、心肌梗死等。
主要发现
- WBC≥10 K/μL组较WBC<10 K/μL组更年轻(71.8 ± 9.5岁 vs 74.1 ± 8.7岁,P < .001),糖尿病、使用类固醇、吸烟、功能依赖和急诊就诊比例更高(均P ≤ .009)。
- WBC≥10 K/μL组动脉瘤直径更大(5.9 ± 1.5 cm vs 5.7 ± 1.5 cm,P < .001)。
- WBC≥10 K/μL组死亡率(2.4% vs 1.3%)、住院>1周(13.5% vs 6.7%)、30天再入院(9.8% vs 7.3%)、下肢缺血(2.3% vs 1.4%)、缺血性结肠炎(1.2% vs 0.5%)和心肌梗死(2.0% vs 1.1%)均更高(均P ≤ .008)。
- 女性WBC≥10 K/μL者较男性WBC≥10 K/μL者死亡、住院>1周、30天再入院和下肢缺血等不良事件更多(均P ≤ .025)。
- WBC每增加1 K/μL,校正后不良结局比值比升高:死亡1.05(95%CI 1.00-1.10)、再入院1.03(95%CI 1.00-1.06)、住院>1周1.08(95%CI 1.05-1.10)、缺血性结肠炎1.11(95%CI 1.05-1.16),均P < .05;该效应在女性中更显著且具统计学意义。
关键数值与推荐
- WBC分组界值为10 K/μL。
- 主要结局为30天死亡率,次要结局包括住院>1周、30天再入院、下肢缺血、缺血性结肠炎和心肌梗死等。
- 多变量logistic回归用于评估WBC每增加1 K/μL的校正比值比。
临床怎么用
- EVAR术前应关注WBC,尤其女性患者WBC≥10 K/μL时提示术后不良结局风险更高。
- 可将术前WBC作为预后因素纳入风险评估,用于识别高危患者并加强围手术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Elevated white blood cell count (WBC) can be predictive of adverse outcomes following vascular interventions, but the association has not established using multi-institutional data. We evaluated the predictive value of preoperative WBC after endovascular aneurysm repair (EVAR) for nonruptured abdominal aortic aneurysms (AAAs) in a nationally representative surgical database. METHODS: Patients with nonruptured AAA undergoing EVAR were identified in the vascular-targeted National Surgical Quality Improvement Program (NSQIP) database. Baseline characteristics were compared between patients with WBC <10 K/μL and WBC ≥10 K/μL. Multivariable logistic regression analyses were performed to assess the odds of outcomes. The primary outcome was 30-day mortality. Multiple secondary outcomes including length of stay (LOS) > 1 week, 30-day readmission, lower extremity (LE) ischemia, ischemic colitis, myocardial infarction, and others were assessed based on WBC and patient sex. RESULTS: A total of 10,955 patients were included, with a mean WBC 7.7 ± 2.7 K/μL. Patients with WBC ≥10 K/μL were younger (71.8 ± 9.5 years vs 74.1 ± 8.7 years; P < .001) and were more likely to be diabetic, on steroids, smokers, functionally dependent, and presenting emergently (all P ≤ .009). Aneurysm diameter was larger in patients with WBC ≥10 K/μL (5.9 ± 1.5 cm vs 5.7 ± 1.5 cm; P < .001). Patients with WBC ≥10 K/μL had more mortality (2.4% vs 1.3%), LOS >1 week (13.5% vs 6.7%), 30-day readmissions (9.8% vs 7.3%), LE ischemia (2.3% vs 1.4%), ischemic colitis (1.2% vs 0.5%), and myocardial infarction (2.0% vs 1.1%) (all P ≤ .008). Female patients with WBC ≥10 K/μL, compared with male patients with WBC ≥10 K/μL, had more adverse events, including mortality, LOS >1 week, 30-day readmission, and LE ischemia (all P ≤ .025). With each incremental increase in WBC by 1 K/μL, the adjusted odds ratio of adverse outcomes for all patient was higher (mortality: 1.05; 95% confidence interval [CI], 1.00-1.10; readmission: 1.03; 95% CI, 1.00-1.06; LOS >1 week: 1.08; 95% CI, 1.05-1.10; and ischemic colitis: 1.11; 95% CI, 1.05-1.16; all P < .05). The effect was more pronounced in female patients and was statistically significant. CONCLUSIONS: WBC is a predictor of adverse outcomes in patients undergoing EVAR for nonruptured AAA. After adjusting for associated risk factors, the effect of increasing WBC was more prominent for female patients. Preoperative WBC should be used as a prognostic factor to predict adverse outcomes among patients undergoing EVAR.
引用
- Nejim B, Chau M, Ramirez Castello C, et al. Preoperative leukocytosis among female patients predicts poor postoperative outcomes following endovascular aneurysm repair for intact infrarenal abdominal aortic aneurysms. J Vasc Surg. 2021. PMID: 34174377. doi:10.1016/j.jvs.2021.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。